<DOC>
	<DOCNO>NCT01370070</DOCNO>
	<brief_summary>To evaluate activity safety MK-2206 patient recurrent metastatic nasopharyngeal carcinoma ( NPC )</brief_summary>
	<brief_title>MK-2206 Recurrent Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Aged &gt; 18 year , able give write informed consent . History histologically cytologically confirm nonkeratinizing NPC recur locoregional and/or distant site , amenable potentially curative radiotherapy surgery . Patients must progress within 24 month receive one two prior line chemotherapy recurrent disease , least one line must contain platinum drug Cisplatin , Carboplatin oxaliplatin . Adequate organ reserve : neutrophil &gt; 1.5x109/L , platelet ≥100 x109/L , hemoglobin ≥9 g/dL , serum alanine aminotransferase ( ALT ) &lt; 2.5 x upper limit normal ( ULN ) ALT &lt; 5 x ULN presence liver metastasis , serum bilirubin &lt; 2.5 x ULN , serum creatinine &lt; 1.5 x ULN . Presence measurable disease per Response Evaluation Criteria Solid Tumors ( RECIST ver 1.1 ) . Chemotherapy , radiotherapy ( except bone metastasis ) investigational treatment within 4 week enrollment . Patients diabetes risk hyperglycemia exclude trial MK2206 , hyperglycemia well control patient enters trial . Cardiovascular : baseline QTcF &gt; 450 msec ( male ) QTcF &gt; 470 msec ( female ) Left bundle branch block , 2nd 3rd degree AV block , bifascicular block , sick sinus syndrome , WolffParkinsonwhite syndrome , significant sinus bradycardia ( &lt; 50bpm ) . However , patient asymptomatic right bundle branch block 1st degree AV block , absence know cardiac disease ( e.g . coronary , valvular ) NOT excluded.. Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>